[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Infinite Biomedical Technologies\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":97},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,46,74],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100557578","regulatory-clearance-of-the-glide-control-strategy-for-upper-limb-prostheses-100557578",false,"NCT06539936","Regulatory Clearance of the Glide Control Strategy for Upper Limb Prostheses","Inclusion Criteria:\n\n* Trans-radial unilateral limb loss\n* Candidate for a multi-articulated myoelectric hand prosthesis as determined by the study prosthetist\n* Minimal residual limb length for myoelectric control as determined by the clinical team\n* Age of 18 years or greater\n\nExclusion Criteria:\n\n* Patients with a residual limb that is unhealed from the amputation surgery\n* Patients with easily damaged or sensitive skin who would not tolerate EMG electrodes\n* Unhealed wounds\n* Significant cognitive deficits as determined upon clinical evaluation\n* Significant neurological deficits as determined upon clinical evaluation\n* Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation\n* Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation\n* Serious uncontrolled medical problems as judged by the project therapist","ALL","18 Years",{"count":18,"type":19},7,"ESTIMATED","INTERVENTIONAL",[22],"NA","The investigators will test the following hypothesis: Use of Glide results in improved functional performance, satisfaction, and usage metrics as compared to use of a standard Direct Control (DC) prosthesis.\n\nThis study will compare the use of Glide \\[Experimental\\] prosthesis with a DC \\[Standard\\] prosthesis in a clinical setting and in unsupervised daily activity. We will follow a multiple baseline design, specifically an AB design. Each of the subjects will use the Experimental and Standard systems over a total of 24-weeks. The A phase is the baseline phase where the DC prosthesis will be used, and the B phase will be the treatment phase where the Glide prosthesis will be used. Participants will undergo an A phase of either 10-weeks, 12-weeks, or 14-weeks duration, with the remaining 14-, 12-, or 10-weeks of the study being dedicated to the B phase.",[25,26],"Amputation","Upper Limb",[28,29,30,31,32],"amputation","upper limb","myoelectric control","prosthesis","glide","RECRUITING","2026-05-27",{"date":36,"type":37},"2026-05-29","ACTUAL",{"date":39,"type":37},"2024-09-16",{"date":41,"type":19},"2027-03-31",{"name":43,"class":44},"Infinite Biomedical Technologies","INDUSTRY",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":20,"phases":55,"briefSummary":56,"conditions":57,"keywords":60,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},"100610015","long-term-stability-of-the-glide-control-strategy-100610015","NCT07222085","Long-Term Stability of the Glide Control Strategy","Determining the Long-Term Stability of the Glide Control Strategy for Upper Limb Prostheses","Inclusion Criteria:\n\n* Unilateral trans-radial or trans-humeral limb loss with a healed residual limb\n* Candidate for 2+ degree-of-freedom (DOF) myoelectric prosthesis as determined by the study prosthetist\n* Age of 18 years or greater\n\nExclusion Criteria:\n\n* Prior experience with Pattern Recognition or Glide control\n* Individuals with a residual limb that is unhealed from the amputation surgery\n* Individuals with easily damaged or sensitive skin who would not tolerate EMG electrodes\n* Significant cognitive deficits as determined upon clinical evaluation\n* Significant neurological deficits as determined upon clinical evaluation\n* Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation\n* Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation\n* Serious uncontrolled medical problems",{"count":54,"type":19},12,[22],"This research is intended to test whether the prescription of the Glide prosthesis control system reduces the burden of use for both patients and their clinical care team as compared to use of Pattern Recognition-based advanced myoelectric control. The goal of the study is to fill the gaps in clinically relevant knowledge to inform the prescription of prosthesis components and the rehabilitation process.",[58,59],"Upper Limb Amputation Above Elbow","Upper Limb Amputation Below Elbow",[61,62,63,64],"Glide","Pattern Recognition","Myoelectric Control","Upper Limb Prostheses","2025-11-03",{"date":67,"type":37},"2025-11-05",{"date":69,"type":37},"2025-10-15",{"date":71,"type":19},"2029-04",{"name":43,"class":44},10,{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":4,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":81,"targetDuration":4,"studyType":20,"phases":83,"briefSummary":84,"conditions":85,"keywords":86,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":45},"100507518","study-of-efficacy-of-the-myotrain-system-in-a-population-of-individuals-with-trans-radial-limb-loss-100507518","NCT05888428","Study of Efficacy of the MyoTrain System in a Population of Individuals With Trans-radial Limb Loss","Regulatory Clearance of a Rehabilitation System for Individuals With Upper Limb Loss","Inclusion Criteria:\n\n* Trans-radial unilateral limb loss\n* Candidate for a 2+ degree-of-freedom myoelectric pattern recognition prosthesis as determined by prosthetist\n* Fluent in English\n* Age of 18 years or greater\n\nExclusion Criteria:\n\n* Prior experience with pattern recognition control\n* Patients with a residual limb that is unhealed from the amputation surgery\n* Patients with easily damaged or sensitive skin who would not tolerate EMG electrodes\n* Unhealed wounds\n* Significant cognitive deficits as determined upon clinical evaluation\n* Significant neurological deficits as determined upon clinical evaluation\n* Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation\n* Uncontrolled pain or phantom pain impactive full participation in the study as determined upon clinical evaluation\n* Serious uncontrolled medical problems as judged by the project therapist",{"count":82,"type":19},16,[22],"The investigators propose to evaluate the efficacy of MyoTrain in a prospective clinical study involving 16 individuals with trans-radial upper-limb loss over a period of 206 days. These individuals will be randomized to Group A (Control Group using standard motor imagery training) and Group B (who are provided the MyoTrain system).\n\nThe investigators will test three hypotheses:\n\n1. The use of MyoTrain results in skills transference to control of the final prosthesis\n2. The virtual outcome measures in MyoTrain are correlated with real-world functional outcome measures\n3. The use of MyoTrain results in improved clinical outcomes as measured by functional, subjective and usage metrics\n\nFollowing a baseline functional assessment, participants will undergo a 30-day pre-prosthetic training period specific to their assigned Group. After this training period, participants will receive their prosthetic device and occupational therapy consistent with the current clinical care standard, after which they will again undergo clinical assessment. Post-device delivery, participants will then complete 3 56-day blocks of at-home prosthesis use, in between which they will return to clinic for assessment.",[25,26],[28,29,87,88,31],"myoelectric","training","2025-10-27",{"date":91,"type":37},"2025-10-29",{"date":93,"type":37},"2024-02-02",{"date":95,"type":19},"2026-08-31",{"name":43,"class":44},""]